G9a promotes muscular atrophy in chronic aging and acute denervation
Authors:
Open Access
- 5 November 2024
- journal article
- research article
- Published by Springer Nature in Animal Diseases
- Vol. 4 (1) , 1-13
Abstract
Muscular atrophy accompanied by neuromuscular junction (NMJ) denervation is often observed after long-term chronic diseases and aging and is associated with substantial morbidity and mortality. Here, we report that histone methyltransferase G9a is elevated in the muscle of muscular atrophy model mice and that muscle-specific deficiency of G9a (Ehmt2Ckmm−KO) alleviates muscular atrophy in both aged and denervated mice. Moreover, increased nerve-to-myofiber ratios and increased Agrin-Lrp4-MuSK signaling, which maintains NMJ, are found in aged Ehmt2Ckmm−KO mice. Together, these data suggest that G9a promotes muscular atrophy and disrupts NMJ; thus, inhibiting the G9a level may be a potential therapy for muscular atrophy.Keywords
Funding Information
- Natural Science Foundation of China (32271222)
This publication has 56 references indexed in Scilit:
- Handelin alleviates cachexia‐ and aging‐induced skeletal muscle atrophy by improving protein homeostasis and inhibiting inflammationJournal of Cachexia, Sarcopenia and Muscle, 2023
- Epigenome‐wide DNA methylation analysis of myasthenia gravisFEBS Open Bio, 2023
- Post‐translational regulation of muscle growth, muscle aging and sarcopeniaJournal of Cachexia, Sarcopenia and Muscle, 2023
- Sarcopenia: Keeping on Search for the Best Operational DefinitionThe Journal of nutrition, health and aging, 2023
- An elusive consensus definition of sarcopenia impedes research and clinical treatment: A narrative reviewAgeing Research Reviews, 2023
- X-linked myotubular myopathy is associated with epigenetic alterations and is ameliorated by HDAC inhibitionActa Neuropathologica, 2022
- Epigenome‐wide association study of sarcopenia: findings from the Hertfordshire Sarcopenia Study (HSS)Journal of Cachexia, Sarcopenia and Muscle, 2021
- Prevalence of sarcopenia according to EWGSOP1 and EWGSOP2 in older adults and their associations with unfavorable health outcomes: a systematic reviewAging Clinical and Experimental Research, 2021
- Molecular mechanisms and therapeutic interventions in sarcopeniaOsteoporosis and Sarcopenia, 2017
- Endocrine regulation of protein breakdown in skeletal muscleDiabetes/Metabolism Research and Reviews, 1988